Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 45 | F | Colon | Tubular adenocarcinoma | 1--2 | T3N0M0 | IIA | Malignant |
A2 | 2 | 45 | F | Colon | Tubular adenocarcinoma | 1--2 | T3N0M0 | IIA | Malignant |
A3 | 3 | 62 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
A4 | 4 | 62 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
A5 | 5 | 50 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant |
A6 | 6 | 50 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant |
A7 | 7 | 70 | M | Prostate | Acinar adenocarcinoma (Gleason grade:5, Gleason score:4+5) | 2--3 | T3N0M0 | III | Malignant |
A8 | 8 | 70 | M | Prostate | Acinar adenocarcinoma (Gleason grade:5, Gleason score:4+5) | 2--3 | T3N0M0 | III | Malignant |
B1 | 9 | 49 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
B2 | 10 | 49 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
B3 | 11 | 48 | M | Lung | Mucinous/non-mucinous adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
B4 | 12 | 48 | M | Lung | Mucinous/non-mucinous adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
B5 | 13 | 38 | F | Breast | Invasive carcinoma of no special type | 2 | T3N1M0 | IIA | Malignant |
B6 | 14 | 38 | F | Breast | Invasive carcinoma of no special type | 2 | T3N1M0 | IIA | Malignant |
B7 | 15 | 56 | M | Prostate | Acinar adenocarcinoma (Gleason grade:5, Gleason score:4+5) | 2 | T3N0M0 | III | Malignant |
B8 | 16 | 56 | M | Prostate | Acinar adenocarcinoma (Gleason grade:5, Gleason score:4+5) | 3 | T3N0M0 | III | Malignant |
C1 | 17 | 44 | F | Colon | Mucinous adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
C2 | 18 | 44 | F | Colon | Mucinous adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
C3 | 19 | 57 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
C4 | 20 | 57 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
C5 | 21 | 48 | F | Breast | Invasive carcinoma of no special type | 2 | T4N2M0 | IIIB | Malignant |
C6 | 22 | 48 | F | Breast | Invasive carcinoma of no special type | 2 | T4N2M0 | IIIB | Malignant |
C7 | 23 | 76 | M | Prostate | Acinar adenocarcinoma (Gleason grade:4, Gleason score:4+4) | 2 | T3N0M0 | III | Malignant |
C8 | 24 | 76 | M | Prostate | Acinar adenocarcinoma (Gleason grade:4, Gleason score:4+4) | 2-3 | T3N0M0 | III | Malignant |
D1 | 25 | 35 | M | Colon | Colon tissue | * | * | * | Normal |
D2 | 26 | 35 | M | Colon | Colon tissue | * | * | * | Normal |
D3 | 27 | 21 | F | Lung | Lung tissue | * | * | * | Normal |
D4 | 28 | 21 | F | Lung | Lung tissue | * | * | * | Normal |
D5 | 29 | 46 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
D6 | 30 | 46 | F | Breast | Adjacent normal breast tissue (fibrofatty tissue) | * | * | * | NAT |
D7 | 31 | 29 | M | Prostate | Prostate tissue | * | * | * | Normal |
D8 | 32 | 29 | M | Prostate | Prostate tissue | * | * | * | Normal |
E1 | 33 | 30 | M | Colon | Colon tissue | * | * | * | Normal |
E2 | 34 | 30 | M | Colon | Colon tissue | * | * | * | Normal |
E3 | 35 | 22 | M | Lung | Lung tissue | * | * | * | Normal |
E4 | 36 | 22 | M | Lung | Lung tissue | * | * | * | Normal |
E5 | 37 | 44 | F | Breast | Adjacent normal breast tissue (sparse) | * | * | * | NAT |
E6 | 38 | 44 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
E7 | 39 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
E8 | 40 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
F1 | 41 | 35 | M | Colon | Ascending colon tissue | * | * | * | Normal |
F2 | 42 | 35 | M | Colon | Ascending colon tissue (sparse) | * | * | * | Normal |
F3 | 43 | 24 | M | Lung | Lung tissue | * | * | * | Normal |
F4 | 44 | 24 | M | Lung | Lung tissue | * | * | * | Normal |
F5 | 45 | 19 | F | Breast | Breast tissue | * | * | * | Normal |
F6 | 46 | 19 | F | Breast | Breast tissue | * | * | * | Normal |
F7 | 47 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
F8 | 48 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |